Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2018 | 2017 | 2016 | 2015 | 2014
Number of items: 20.

2018

Meder, L., Koenig, K., Dietlein, F., Florin, A., Koker, M., Buettner, R., Heukamp, L. and Ullrich, R. (2018). LIN28B enhanced tumorigenesis in an autochthonous KRASG12V driven lung carcinoma mouse model. Oncol. Res. Treat., 41. S. 291 - 292. BASEL: KARGER. ISSN 2296-5262

2017

Michels, S., Heydt, C., Deschler-Baier, B., Ruesseler, V., Stratmann, J., Steinhauser, S., Fischer, R., Scheffler, M., Fassunke, J., Kron, A., Griesinger, F., Gautschi, O., Sebastian, M., Hellmich, M., Heukamp, L., Merkelbach-Bruse, S., Bttner, R. and Wolf, J. (2017). Molecular panel sequencing of pre-treatment samples reveals mechanisms of innate resistance to 3rd generation EGFR TKI treatment in T790M-positive NSCLC patients. Oncol. Res. Treat., 40. S. 134 - 135. BASEL: KARGER. ISSN 2296-5262

Roeper, J., Lueers, A., Netchaeva, M., Falk, M., Hallas, C., Tiemann, M., Neemann, N., Heukamp, L., Wesseler, C., Wiest, G. H., Ukena, D., Sackmann, S. and Griesinger, F. (2017). Impact on OS and PFS of 2nd and 3rd generation TKI in EGFR mt1 and ALK1 pts: Results of the NOWEL network. Ann. Oncol., 28. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

2016

Goktuna, S., Shostak, K., Chau, T. L., Heukamp, L., Close, P., Rahmouni, S., Van Loo, G., Buttner, R., Greten, F. and Chariot, A. (2016). IKK epsilon/IKBKE integrates LPS and IL-17A signaling cascades to establish an inflammatory microenvironment in intestinal tumors. Eur. J. Cancer, 61. S. S213 - 2. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Menon, R., Mueller, J., Heuckmann, J., Lueers, A., Heukamp, L., Wolf, J. and Griesinger, F. (2016). Discovery of a novel EGFR resistance mutation by capture based NGS following AZD9291 treatment. Oncol. Res. Treat., 39. S. 120 - 121. BASEL: KARGER. ISSN 2296-5262

Vollbrecht, C., Mairinger, F. D., Koitzsch, U., Peifer, M., Koenig, K., Heukamp, L., Crispatzu, G., Wilden, L., Kreuzer, K-A, Hallek, M., Odenthal, M., Herling, C. D. and Buettner, R. (2016). Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing. Oncol. Res. Treat., 39. S. 159 - 160. BASEL: KARGER. ISSN 2296-5262

2015

Frank, R., Scheffler, M., Michels, S., Eisert, A., Fischer, R., Koenig, K., Merkelbach-Bruse, S., Serke, M., Ko, Y. D., Gerigk, U., Geist, T., Heukamp, L., Buettner, R. and Wolf, J. (2015). KEAP1-mutations and NFE2L2-mutations in patients with non-small cell lung cancer (NSCLC). Eur. J. Cancer, 51. S. S645 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Frank, R., Scheffler, M., Michels, S., Eisert, A., Gogl, L., Fischer, R., Koenig, K., Merkelbach-Bruse, S., Serke, M., Ko, Y. -D, Gerigk, U., Geist, T., Heukamp, L., Buettner, R. and Wolf, J. (2015). KEAP1-mutations and NFE2L2-mutations in patients with non-small cell lung cancer (NSCLC). Oncol. Res. Treat., 38. S. 268 - 269. BASEL: KARGER. ISSN 2296-5262

Griesinger, F., Cappuzzo, F., Dziadziuszko, R., Reck, M., Lantuejoul, S., Eberhardt, W., Tiemann, M., Heukamp, L., Menon, R. and Heuckmann, J. (2015). Comparison of fluorescence in-situ hybridization and hybrid capture based NGS sequencing for fusion detection in primary tumor specimen of the lung. Oncol. Res. Treat., 38. S. 269 - 271. BASEL: KARGER. ISSN 2296-5262

Griesinger, F., Sebastian, M., Serke, M., Buettner, R., Waller, C., Reinmuth, N., Graeven, U., Lueers, A., Radke, S., Karatas, A., Heukamp, L., Tiemann, M. and Overbeck, T. (2015). Induction therapy with intercalated TKI and chemotherapy in NSCLC with activating EGFR mutation in stages II-IIIB: Neolntercal. Oncol. Res. Treat., 38. S. 140 - 141. BASEL: KARGER. ISSN 2296-5262

2014

Frank, R., Scheffler, M., Michels, S., Koenig, K., Merkelbach-Bruse, S., Serke, M., Ko, Y. -D, Gerigk, U., Geist, T., Heukamp, L., Buettner, R. and Wolf, J. (2014). Occurrence and characteristics of KEAP1-mutations in patients with non-small cell lung cancer (NSCLC). Oncol. Res. Treat., 37. S. 8 - 9. BASEL: KARGER. ISSN 2296-5262

Gautschi, O., Pall, G., Schultheis, A., Keller, F. Aebersold, Gardizi, M., Heuckmann, J., Merkelbach-Bruse, S., Diebold, J., Wolf, J. and Heukamp, L. (2014). LUNG ADENOCARCINOMA WITH RET FUSION: EARLY EXPERIENCE WITH DIAGNOSIS AND TARGETED THERAPY. J. Thorac. Oncol., 9 (4). S. S38 - 1. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1556-1380

Koenig, K., Peifer, M., Bos, M., Nogova, L., Merkelbach-Bruse, S., Stamm, K., Henkel, T., Thomas, R., Wolf, J., Buettner, R. and Heukamp, L. (2014). High throughput parallel amplicon sequencing of common driver mutations from FFPE lung cancer samples in molecular pathological routine diagnostics for a regional health care provider network. Oncol. Res. Treat., 37. S. 31 - 33. BASEL: KARGER. ISSN 2296-5262

Kron, F., Glossmann, J. P., Lotze, M., Barsoum, M., Winters, S., Normolle, D., Boyiadzis, M., Socinski, M., Bernschein, A., Schmidt-Wolf, I., Funke, B., Meyer, M., von Levetzow, C., Leitzke, S., Hellmich, M., Scheid, C., Kreuzer, K. -A., Kostenko, A., Waldschmidt, D., Heukamp, L., Zander, T., Scheffler, M., Hallek, M. and Wolf, J. (2014). A benchmark study of cancer patient outcome in two Comprehensive Cancer Centers in the US and Germany. Oncol. Res. Treat., 37. S. 95 - 96. BASEL: KARGER. ISSN 2296-5262

Michels, S., Gardizi, M., Schultheis, A., Scheffler, M., Karachaliou, N., Teixido, C., Heukamp, L., Merkelbach-Bruse, S., Thurat, M., Nogova, L., Bos, M., Mattonet, C., Grohe, C., Sebastian, M., Thomas, M., Reck, M., Stahel, R., Pirker, R., Zoechbauer-Mueller, S., Groen, H., Dingemanns, A. -M, Smit, E., Thomas, R., Buettner, R., Massuti, B., Rosell, R. and Wolf, J. (2014). EUCROSS: A phase II trial to evaluate efficacy and safety of crizotinib treatment in advanced adenocarcinoma of the lung harbouring ROS1 translocations. Oncol. Res. Treat., 37. S. 65 - 66. BASEL: KARGER. ISSN 2296-5262

Michels, S., Schultheis, A., Scheffler, M., Rosner, T., Merkelbach-Bruse, S., Heukamp, L., Engel-Riedel, W., Serke, M., Krueger, S., Benedikter, J., Gerigk, U., Schulte, W., Draube, A., Ko, Y. D., Buettner, R. and Wolf, J. (2014). RET rearrangement in adenocarcinoma of the lung. Oncol. Res. Treat., 37. S. 6 - 7. BASEL: KARGER. ISSN 2296-5262

Nogova, L., Gardizi, M., Bos, M., Scheffler, M., Papachristou, I., Woempner, C., Heukamp, L., Schildhaus, H. -U., Fuhr, U., Sos, M., Eberhardt, W., Wiesweg, M., Schmid, K. W., Schuler, M., Thomas, R., Buettner, R. and Wolf, J. (2014). TRY: A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation. Oncol. Res. Treat., 37. S. 92 - 93. BASEL: KARGER. ISSN 2296-5262

Nogova, L., Mattonet, C., Gardizi, M., Scheffler, M., Bos, M., Woempner, C., Toepelt, K., Heukamp, L., Suleiman, A., Frechen, S., Soergel, F., Fuhr, U., Schnell, R., Katay, I., Behringer, D., Geist, T., Kaminski, B., Eichstaedt, M., Tummes, D., Buettner, R. and Wolf, J. (2014). SORAVE: Sorafenib and everolimus for patients with solid tumors and with KRAS mutated NSCLC - results of a phase I study. Oncol. Res. Treat., 37. S. 32 - 33. BASEL: KARGER. ISSN 2296-5262

Scheffler, M., Bos, M., Sos, M., Nogova, L., Gardizi, M., Mattonet, C., Papachristou, I., Kahraman, D., Kobe, C., Lammertsma, A., Boellaard, R., Persigehl, T., Heukamp, L., Buettner, R., Elter, T., Toepelt, K., Engel-Riedel, W., Stoelben, E., Neumaier, B., Dietlein, M., Zander, T. and Wolf, J. (2014). MIMEB: A phase II trial to evaluate FDG-PET/FLT-PET and DCE-MRI for early prediction of efficacy in patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab. Oncol. Res. Treat., 37. S. 92 - 93. BASEL: KARGER. ISSN 2296-5262

Scheffler, M., Gardizi, M., Bos, M., Heukamp, L., Koenig, K., Serke, M., Nogova, L., Toepelt, K., Stoelben, E., Engel-Riedel, W., Randerath, W., Kaminsky, B., Panse, J., Zander, T., Buettner, R. and Wolf, J. (2014). Clinical and Molecular Characteristics of Non-Small Cell Lung Cancer Patients Harboring PIK3CA Mutations. Oncol. Res. Treat., 37. S. 92 - 93. BASEL: KARGER. ISSN 2296-5262

This list was generated on Thu Dec 9 05:30:53 2021 CET.